Aicuris Gmbh + Co. Kg.

Bayer Aktiengesellschaft

Bayer Cropscience Ag

Bayer Intellectual Property Gmbh

Bayer Pharma Aktiengesellschaft

Bayer Animal Health Gmbh

Elanco Animal Health Gmbh

Joachim Telser

Rainer Endermann

Joachim Schuhmacher

Franz Von Nussbaum

Nina Brunner

Jacques Ragot

Andreas Turberg

Elke Hartmann

Guido Schiffer

Peter Jeschke

Kerstin Ilg

Hans-Georg Schwarz

Yolanda Cancho Grande

Alexander Arlt

Ulrich Ebbinghaus-Kintscher

Iring Heisler

Niels Svenstrup

Martin Fuesslein

Michael-Alexander Bruening

Ulrike Wachendorff-Neumann

Pierre Wasnaire

Ulrich Goergens

Werner Hallenbach

Mario Lobell

Heinz-Juergen Wroblowsky

Marc Linka

Arunas Jonas Damijonaitis

Tomoki Tsuchiya

Mark James Ford

Mazen Es-Sayed

Sebastian Hoffmann

Stefan Hillebrand

Niels Lindner

Jürgen Klar

Estella Buscato Arsequell

Guenter Hoemberger

Andreas Schall

Michael Böttger

Thomas Schlange

Peter Dahmen

Karl-Heinz Schlemmer

Ulrich Görgens

Pierre Cristau

Sergii Pazenok

Frank Süβmeier

Dieter Lang

Ulf Bömer

Rudolf Schohe-Loop

Sonja Anlauf

Chantal Fuerstner

Volkhart Min-Jian Li

Philippe Rinolfi

Hans Briem

Alexandros Vakalopoulos

Klemens Lustig

Peter Lösel

Jörg Keldenich

Bernd Buchmann

Lars Bärfacker

Walter Hübsch

Hans-Christian Militzer

Joerg Keldenich

Peter Nell

Johannes Köbberling

Hartmut Schirok

Hartmut Beck

Barbara Albrecht-Küpper

Stefan Golz

Ursula Krenz

Michael Härter

Peter Loesel

Holger Paulsen

Kersten Matthias Gericke

Kirsten Börngen

Matthias Riedrich

Georges Von Degenfeld

Dirk Brohm

Susanne Greschat

Frank Süssmeier

Johannes Koebberling

Valerie Toquin

Antje Kahnert

Hannah Jörißen

Martin Füsslein

Yolanda Cancho-Grande

Sylvia Grünewald

Verena Vöhringer

Martin Füßlein

Hannah Jöriβen

Wenlang Fu

Kirsten Boerngen

Mélanie Héroult

Verena Voehringer

Franziska Schmidt

Melanie Heroult

Werner Schroeder

Günter Hömberger

Steffen Müller

Hanna Eilken

Dmitrij Hristodorov

The present invention relates to novel heteroaryl-substituted aminoalkyl azole compounds of the general formula (I), in which the structural elements Y, Q, Q, R, R, Rand Rhave the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals.

Heteroaryl-substituted aminoalkyl azole compounds as pesticides

The present invention relates to novel heteroaryl-triazole and heteroaryl-tetrazole compounds of the general formula (I), in which the structural elements Y, Q, Q, R, R, R, Rand Rhave the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals.

Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides

The present invention relates to novel heteroaryl-triazole and heteroaryl-tetrazole compounds of the general formula (I), in which the structural elements Y, Q, Q, R, R, R, Rand Rhave the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals. 

The present invention relates to novel halogen-substituted compounds, to processes for their preparation and to their use for controlling animal pests, in particular arthropods and especially insects and arachnids.

Compounds for controlling arthropods

The present invention relates to novel pyrazole derivatives, to processes for preparing these compounds, to compositions comprising these compounds, and to the use thereof as biologically active compounds, especially for controlling harmful microorganisms in crop protection and in the protection of materials. Further, the present invention also relates to certain intermediates useful for producing said novel pyrazole derivatives.

Pyrazole derivatives

The present application relates to novel (3-hydroxyphenyl)amino-substituted pyrido[2,3-b][1,5]benzodiazepin-5-one derivatives, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially of angiogenic disorders and hyperproliferative disorders in which neovascularization plays a role, for example ophthalmological disorders and cancers and tumours. Such treatments can be effected as monotherapy or else in combination with other medicaments or further therapeutic measures.

Substituted pyridobenzodiazepinone-derivatives and use thereof

Malonic ester derivatives of the formula (I) in which the symbols A, A, Y, R, p, X, R, G, Q, Land Rare each as defined in the description, and salts, metal complexes and N-oxides of the compounds of the formula (I), and the use thereof for controlling phytopathogenic harmful fungi and processes for preparing compounds of the formula (I).

Malonic ester derivatives of heteroarylpiperidines and -piperazines as fungicides

Piperidinecarboxylic acidderivatives of the formula (I) in which the symbols A, L, L, G, p, Q, R, R, T and Y are each as defined in the description, and salts, metal complexes and N-oxides of the compounds of the formula (I), and the use thereof for controlling phytopathogenic harmful fungi and processes for preparing compounds of the formula (I).

Piperidinecarboxylic acid derivatives as fungicides

The present application relates to novel 1-phenyl-1H-imidazo[1,2-b]pyrazole derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular angiogenic disorders and hyperproliferative disorders, where neovascularization plays a role, such as, for example, neoplastic disorders and tumor disorders. Such treatments can be carried out as monotherapy or else in combination with other medicaments or further therapeutic measures.

Substituted phenylimidazopyrazoles and their use

This invention relates to novel 5-[(hydroxymethyl)aryl]-substituted pyrrolo[2,1-f][1,2,4]triazin-4-amines of formula (I), to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating angiogenesis-related disorders, in particular angiogenesis-related ocular disorders. 

Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors

The present application relates to novel 4-cycloalkyl- and 4-heterocycloalkyl-3,5-dicyano-2-thio-pyridine derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of hypertension and other cardiovascular disorders.

Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof

The invention relates to lysobactin amides and methods for their preparation, as well as their use for manufacturing medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.

Lysobactin amides

The invention relates to nonadepsipeptides and methods for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.

Substituted nonadepsipeptides

Nonadepsipeptides and methods for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases are described.

Deoxonadepsipeptides

Growing community of inventors

Wuppertal, Germany

Joachim Telser